Lawrence Friedhoff

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

Samantha Rogers, Martin R. Farlow, Rachelle S. Doody et al. · Neurology · 1998 · 1.6K citations

Neuropsychology, Placebo-controlled Trial, Pharmacotherapy +20

The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial

Sharon L. Rogers, Lawrence Friedhoff · Dementia and Geriatric Cognitive Disorders · 1996 · 738 citations

DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study

Ilise Lombardo, Geetha Ramaswamy, Stephen C. Piscitelli et al. · Alzheimer s & Dementia · 2015 · 656 citations

Neuropsychology, Receptor Antagonist, Neurochemical Biomarkers +20

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>

Alistair Burns, Martin N. Rossor, Jane Hecker et al. · Dementia and Geriatric Cognitive Disorders · 1999 · 581 citations · Full text

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

Samantha Rogers, Lawrence Friedhoff · European Neuropsychopharmacology · 1998 · 293 citations

Interim Analysis, Alzheimer's Disease, Long-term Efficacy +8